Study to investigate safety, tolerability, PK and PD response of SLN360 in subjects with elevated lipoprotein(a) (APOLLO) (NCT0406602)

Educational Partners and Supporters

Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum. (Founding Partner)